Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Verona Pharma plc

Annual Financial Report

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019

Inventiva completes a capital increase of € 8.2 million subscribed by leading US and European biotech investors

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Inventiva Pharma

ASLAN Pharmaceuticals Presents Late-Breaking Data From Phase 2 Study in China Testing Varlitinib in Second Line Biliary Tract Cancer at CSCO

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  ASLAN Pharmaceuticals Pte Ltd

Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019

Taiwan Medical Professionals Assisting Malaysian Patients Rediscover Their Confidence and Rediscover Life

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire/ -- Taiwan's medical care is renowned for its high quality, advanced technology, professionalism and affordable pricing. In fact, the cost of medical treatment in Taiwan is typically one-fifth of comparable services in Europe and the US. To further... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Taiwan External Trade Development Council (TAITRA)

'Find the Children - 60 in India With Progeria' Campaign Reignites the Search for Children With Progeria in India

MUMBAI, Sept. 19, 2019 /PRNewswire/ -- The Progeria Research Foundation (PRF; www.progeriaresearch.org), the only organization in the world dedicated to discovering treatments and the cure for children with Progeria, today announced... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  The Progeria Research Foundation

Maharashtra Witnesses for the First Time, Sahyadri Hospitals Performing 5 Major Organ Transplants in a day

- 23 year old students gives a new lease of life to three needy patients

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2019

Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the results... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Innovent Biologics Co., Ltd.

Medical Optometry America Announces First Regional Practice Agreement

BLUE BELL, Pa. and ASHBURN, Va., Sept. 19, 2019 /PRNewswire/ -- Medical Optometry America (MOA) is excited to announce that it has signed an agreement with Associates in Eyecare - Optometrists (AIE) under which AIE will become the nation's first group of independent optometric practices to adopt... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019

Oxford Nanopore Announces That It Has Entered Into a Non-exclusive Agreement With Caribou Biosciences for CRISPR-Cas9 Enrichment for Nanopore Sequencing

OXFORD, England, Sept. 19, 2019 /PRNewswire/ -- Oxford Nanopore and Caribou Biosciences, Inc. have entered into a non-exclusive license agreement under which Caribou has granted Oxford Nanopore a worldwide, non-exclusive license under foundational CRISPR-Cas9 intellectual property controlled... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019

St. Pölten University of Applied Sciences: Lower-Extremity Strengthening Training for Overweight Children

ST. PÖLTEN, Austria, Sept. 19, 2019 /PRNewswire/ -- Obesity can damage the joints and increases the risk of developing joint osteoarthritis - which means suffering from joint wear - early on. The project "Children's KNEEs", a project of the St. Pölten University of Applied Sciences in collaboration... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019

Excelera® Innovates Process for Assessing Medication Adherence Across Nationwide Network of Health System Specialty Pharmacies

MINNEAPOLIS, Sept. 19, 2019 /PRNewswire/ -- Excelera(®) today announced the company has established a systematic process for measuring medication adherence among patients taking specialty medications in the Excelera Network, a nationwide network of health systems with integrated specialty pharmacies.... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  ExceleraRx Corp.

Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming

BOSTON, Sept. 19, 2019 /PRNewswire/ -- Today, Ginkgo Bioworks, the organism company, announced a Series E financing... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Ginkgo BioWorks

Baylis Medical Announces Presentation Lineup for Transcatheter Cardiovascular Therapies 2019 Conference

TORONTO, Sept. 19, 2019 /CNW Telbec/ - Baylis Medical announced today key activities that will be featured at Transcatheter Cardiovascular Therapeutics (TCT) 2019, the Cardiovascular Research Foundation's 31st annual conference and premier interventional cardiovascular medicine educational meeting,... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019

El Camino Health leverages Seabright Healthcare Solutions proprietary analytics tools and saves $1.5M

SAN JOSE, Calif., Sept. 19, 2019 /PRNewswire/ -- Seabright Healthcare recently completed a project at El Camino Health hospitals focused on reducing the cost of spinal implants and supplies. Using Seabright's analytics and proprietary algorithms, El Camino Health was able to bring together its... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Camino Pharma, LLC | Camino Real Capital Partners, LLC

Tresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes

BARCELONA, Spain, Sept. 19, 2019 /PRNewswire/ -- According to new data from the CONCLUDE head-to-head trial, Tresiba(®) (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA(1c), compared with insulin glargine... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Novo Nordisk Inc.

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

BASEL, Switzerland, Sept. 19, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Novartis International AG | Novartis Venture Fund | Novartis Pharma Schweiz AG | Novartis Pharma AG

Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sequana Medical Appoints Leading Experts as Heart Failure Scientific Advisors

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Sequana Medical, Inc. | Sequana Medical NV | Sequana Medical NV
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑